Oncotherm Kft.

Oncotherm Kft. has been developing, manufacturing, and marketing innovative cancer treatment systems since 1988. Oncotherm’s devices are designed to deliver controlled, loco-regional treatment to tumors using its innovative technology of Oncothermia (modulated electro-hyperthermia, mEHT®).

Our medical devices are CE-marked and comply with the requirements of Regulation (EU) 2017/745 on medical devices (MDR).

What is Oncothermia?

Oncothermia is a unique advancement in conventional oncological hyperthermia, representing a new generation of cancer treatment approaches with a growing scientific foundation across preclinical and clinical research. Unlike conventional hyperthermia, Oncothermia uses a precisely controlled electric field to selectively target malignant tissue and stimulate natural cellular and biological processes.

With its non-invasive and non-toxic approach, Oncothermia is designed to complement conventional cancer treatments and offers new possibilities in the integrative treatment of cancer.

Today, Oncotherm’s devices are used in more than 35 countries worldwide, supporting cancer care with more than 450,000 treatments every year. This growing international experience reflects the potential of Oncothermia as an innovative treatment approach and opens new possibilities for patients and healthcare professionals worldwide.